Company / Interest Expense
PROCEPT BioRobotics Corp Interest Expense History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.0M
FY2023
5-year range
$4.0M / $5.8M
FY2020-FY2023
Trend
-22.9%
vs FY2022
Sector context
#38 of 41
Health Care
What the data says
Among 41 Health Care companies, PROCEPT BioRobotics Corp is in the top 7% for interest expense. Improved from $6M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2023 with a 3-year CAGR of -8.8%.
Improved from $6M to $4M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -8.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 41This company $4.0M Sector average $325.2M
▼
-98.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -8.8%, indicating a declining trend.
- In FY2023, interest expense decreased 22.9% year-over-year.
- Ranks #38 out of 41 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $4.0M | -22.9% |
| FY2022 | $5.2M | -10.8% |
| FY2021 | $5.8M | +10.4% |
| FY2020 | $5.3M | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026